{"id":"W4322754219","doi":"10.1093/noajnl/vdad018","title":"Phase II multicenter trial combining nivolumab and radiosurgery for NSCLC and RCC brain metastases","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology Advances","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Public Health Ontario; Université de Sherbrooke; McGill University Health Centre; Centre Hospitalier Universitaire de Sherbrooke; Princess Margaret Cancer Centre; Centre Hospitalier de l’Université de Montréal; University of Toronto; University Health Network","funders":"Bristol-Myers Squibb","keywords":"Nivolumab; Medicine; Clinical endpoint; Renal cell carcinoma; Radiosurgery; Lung cancer; Internal medicine; Adverse effect; Phases of clinical research; Oncology; Progression-free survival; Urology; Randomized controlled trial; Surgery; Gastroenterology; Clinical trial; Radiation therapy; Immunotherapy; Cancer; Overall survival","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005190715,0.0002178903,0.000631141,0.000169684,0.0003024345,0.00001790766,0.0000455735,0.0000805305,0.00003217753],"category_scores_gemma":[0.0009859535,0.0001784397,0.0001148341,0.0001674957,0.0002380464,0.0001619557,0.00008157081,0.0001478861,0.000004960281],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002875477,"about_ca_system_score_gemma":0.00007317744,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005356362,"about_ca_topic_score_gemma":0.00001255518,"domain_scores_codex":[0.998481,0.0001896883,0.0003409689,0.0004770856,0.0001315583,0.0003796421],"domain_scores_gemma":[0.9963289,0.003121788,0.0001421452,0.0001815389,0.00004364959,0.0001819549],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.09817751,0.004518232,0.002132109,0.000358526,0.0006876344,0.001547558,0.0008481235,0.00001502978,0.02109124,0.0009290742,0.02912286,0.8405721],"study_design_scores_gemma":[0.3527391,0.02985762,0.0005357971,0.00007286677,0.0007443712,0.0003235927,0.0006377558,0.0009986776,0.002783002,0.0005614714,0.6104569,0.0002888713],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9857139,0.003424529,0.0001802696,0.007777168,0.0009824794,0.001533082,0.0001423805,0.0001345088,0.0001116742],"genre_scores_gemma":[0.9899873,0.00155608,0.003581766,0.003538239,0.0003649452,0.0004470182,0.0001898327,0.0000486363,0.0002861753],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8402832,"threshold_uncertainty_score":0.727656,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03763381721113974,"score_gpt":0.3684158237246569,"score_spread":0.3307820065135172,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}